CLINICAL DEVELOPMENT      

We partner and collaborate with other innovator healthcare companies to in-/out-license or co-develop therapeutic and preventative candidates in the clinical phase of the development process. 

Our team members have extensive clinical drug development experience in the following therapeutic areas including biologics and medical devices:

• Cardiovascular Diseases

• Dermatology

• Oncology

• Endocrinology

• Gastroenterology

• Nephrology

• Hematology

• Neurology

• Oncology

• Ophthalmology

• Urology

• Pain Management

• Immunology / Autoimmune

• Pulmonary / Respiratory

• Psychiatry

• Rheumatology

• Infectious Diseases

• Central Nervous System

Development of safe drugs, biologics, vaccines and medical devices is critical to their pre- and post-approval therapeutic success. Over two decades of experience working directly with the US FDA and Health Canada has greatly enhanced our patient and drug safety expertise.  

In addition to the United States Food and Drug Administration (FDA) and Health Canada, the DELTA team also has experience in working with the European Medicines Agency (EMA), Ministry of Health Mexico, Argentina Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT) and the Ministry of Health Turkey. ​